共受体神经纤毛蛋白-1通过VEGF信号促进inv(16)急性髓系白血病增殖
本研究探讨inv(16)急性髓系白血病中融合癌蛋白CBFβ::MYH11对神经纤毛蛋白-1(NRP1)的调控及其促增殖作用。机制上CBFβ::MYH11通过ERG、GATA2和RUNX1维持NRP1表达,NRP1经其VEGFR相关FV/FVIII结构域促进白血病细胞体外及小鼠体内扩增,VEGF抑制剂阿昔替尼可减少AML细胞生长并延迟中位白血病潜伏期。
要点
- inv(16)AML中NRP1表达受融合癌蛋白CBFβ::MYH11调控,NRP1位点染色质开放。
- CBFβ::MYH11敲低抑制ERG表达,使GATA2/RUNX1在三个NRP1增强子处发挥抑制作用。
- NRP1经VEGFR相关FV/FVIII结构域促进白血病细胞扩增,阿昔替尼在体内减少AML细胞生长并延迟中位白血病潜伏期。
核心结论
- NRP1/VEGF轴介导inv(16)AML原始细胞的增殖,作者认为靶向NRP1功能在联合AML治疗中可能具有前景。
研究设计与样本
- 基础实验研究,采用inv(16)AML模型,在体外和 mice(小鼠)中评估NRP1功能及阿昔替尼作用。
主要发现
- inv(16)AML中NRP1位点染色质开放,CBFβ::MYH11调控ERG、GATA2和RUNX1以维持NRP1水平。
- ERG激活NRP1表达,CBFβ::MYH11敲低抑制ERG表达,使GATA2/RUNX1在三个NRP1增强子处发挥抑制活性。
- NRP1促进白血病细胞体外和小鼠体内扩增,该活性依赖其VEGFR相关FV/FVIII结构域。
- 阿昔替尼治疗减少AML细胞生长并延迟体内中位白血病潜伏期。
临床怎么用
- 作者认为靶向NRP1功能在联合AML治疗中可能具有前景,原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Oncogenic programs regulate the proliferation and maintenance of cancer stem cells, and can define pharmacologic dependencies. In acute myeloid leukemia (AML) with the chromosome inversion 16 (inv(16)), the fusion oncoprotein CBFβ::MYH11 regulates pathways associated with leukemia stem cell activity. Here we demonstrate that expression of Neuropilin-1 (NRP1) is regulated by the fusion oncoprotein, and promotes AML expansion. Mechanistically, we show that the NRP1 locus has open chromatin in inv(16) AML, and that CBFβ::MYH11 modulates the local function of the transcription factors ERG, GATA2 and RUNX1 to sustain NRP1 levels. We found that ERG activates NRP1 expression, and that CBFβ::MYH11 knockdown represses ERG expression, thereby allowing the repressive activity of GATA2/RUNX1 at three NRP1 enhancers. Functionally, we demonstrate that NRP1 enhances the expansion of leukemic cells in vitro and in mice, and that this activity is dependent on its VEGFR-associated FV/FVIII domain. Finally, we show that treatment with VEGF inhibitor axitinib reduces AML cell growth and delays median leukemia latency in vivo. Our findings reveal that the NRP1/VEGF axis mediates proliferation in inv(16) AML blasts, and suggest that targeting NRP1 function could be promising in combination AML therapy.
引用
- Hegde M, Ahmad MH, Mulet Lazaro R, et al. The co-receptor Neuropilin-1 enhances proliferation in inv(16) acute myeloid leukemia via VEGF signaling. Leukemia. 2024. PMID: 39572712. doi:10.1038/s41375-024-02471-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。